UA66767C2
(uk)
|
1996-10-18 |
2004-06-15 |
Вертекс Фармасьютикалс Інкорпорейтед |
Інгібітори серин-протеаз, фармацевтична композиція, спосіб інгібування активності та спосіб лікування або профілактики вірусної інфекції гепатиту с
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
DE14169110T1
(de)
|
2002-06-28 |
2022-05-12 |
Centre National De La Recherche Scientifique -Cnrs- |
Modifizierte 2'- und 3'-Nukleosid-Prodrugs zur Behandlung von Flaviridae-Infektionen
|
EP1408031A1
(en)
*
|
2002-10-09 |
2004-04-14 |
3 D Gene Pharma |
Pyrolidine derivatives useful in treatment of hepatitis C virus infection
|
US7429572B2
(en)
|
2003-05-30 |
2008-09-30 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
US20050075309A1
(en)
|
2003-07-25 |
2005-04-07 |
Richard Storer |
Purine nucleoside analogues for treating Flaviviridae including hepatitis C
|
MXPA06002250A
(es)
|
2003-08-26 |
2006-05-17 |
Schering Corp |
Inhibidores peptidomimeticos novedosos de la serina proteasa ns3 del virus de la hepatitis c.
|
TWI359147B
(en)
|
2003-09-05 |
2012-03-01 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hcv n
|
JP4525982B2
(ja)
*
|
2003-09-26 |
2010-08-18 |
シェーリング コーポレイション |
C型肝炎ウイルスのns3セリンプロテアーゼの大環状インヒビター
|
EP1689770A1
(en)
|
2003-11-20 |
2006-08-16 |
Schering Corporation |
Depeptidized inhibitors of hepatitis c virus ns3 protease
|
TW200518746A
(en)
|
2003-12-11 |
2005-06-16 |
Schering Corp |
Novel inhibitors of hepatitis C virus NS3/NS4A serine protease
|
GB0500020D0
(en)
|
2005-01-04 |
2005-02-09 |
Novartis Ag |
Organic compounds
|
WO2005073195A2
(en)
*
|
2004-01-30 |
2005-08-11 |
Medivir Ab |
Hcv ns-3 serine protease inhibitors
|
US20050182252A1
(en)
|
2004-02-13 |
2005-08-18 |
Reddy K. R. |
Novel 2'-C-methyl nucleoside derivatives
|
CN1950393A
(zh)
|
2004-02-27 |
2007-04-18 |
先灵公司 |
丙型肝炎病毒ns3蛋白酶的抑制剂
|
US7192957B2
(en)
*
|
2004-02-27 |
2007-03-20 |
Schering Corporation |
Compounds as inhibitors of hepatitis C virus NS3 serine protease
|
US7816326B2
(en)
*
|
2004-02-27 |
2010-10-19 |
Schering Corporation |
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
|
WO2005087730A1
(en)
|
2004-02-27 |
2005-09-22 |
Schering Corporation |
3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease
|
AU2005222056A1
(en)
|
2004-02-27 |
2005-09-22 |
Schering Corporation |
Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
|
SG186041A1
(en)
*
|
2004-02-27 |
2012-12-28 |
Merck Sharp & Dohme |
Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
|
MXPA06013404A
(es)
|
2004-05-20 |
2007-01-23 |
Schering Corp |
Prolinas sustituidas como inhibidores de serina proteasa ns3 de virus de hepatitis c.
|
AU2005254057B2
(en)
|
2004-06-15 |
2011-02-17 |
Isis Pharmaceuticals, Inc. |
C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase
|
CA2571079A1
(en)
|
2004-06-24 |
2006-02-02 |
Merck & Co., Inc. |
Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
|
JP2008511633A
(ja)
|
2004-08-27 |
2008-04-17 |
シェーリング コーポレイション |
C型肝炎ウィルスns3セリンプロテアーゼの阻害因子としてのアシルスルホンアミド化合物
|
WO2006031725A2
(en)
|
2004-09-14 |
2006-03-23 |
Pharmasset, Inc. |
Preparation of 2'fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
|
CA2606195C
(en)
|
2005-05-02 |
2015-03-31 |
Merck And Co., Inc. |
Hcv ns3 protease inhibitors
|
PE20070011A1
(es)
*
|
2005-06-02 |
2007-03-08 |
Schering Corp |
Formulaciones farmaceuticas de compuestos inhibidores de proteasa del vhc o catepsina
|
EP1891089B1
(en)
|
2005-06-02 |
2014-11-05 |
Merck Sharp & Dohme Corp. |
HCV protease inhibitors in combination with food
|
US20070237818A1
(en)
*
|
2005-06-02 |
2007-10-11 |
Malcolm Bruce A |
Controlled-release formulation of HCV protease inhibitor and methods using the same
|
CN101242842A
(zh)
|
2005-06-17 |
2008-08-13 |
诺瓦提斯公司 |
Sanglifehrin在hcv中的用途
|
US20110104109A1
(en)
*
|
2005-07-13 |
2011-05-05 |
Frank Bennett |
Tetracyclic indole derivatives and their use for treating or preventing viral infections
|
TWI387603B
(zh)
|
2005-07-20 |
2013-03-01 |
Merck Sharp & Dohme |
Hcv ns3蛋白酶抑制劑
|
US8278322B2
(en)
|
2005-08-01 |
2012-10-02 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
CA2618560A1
(en)
|
2005-08-09 |
2007-02-22 |
Merck & Co., Inc. |
Ribonucleoside cyclic acetal derivatives for the treatment of rna-dependent rna viral infection
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
US7705138B2
(en)
*
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
NZ568324A
(en)
|
2005-11-11 |
2012-01-12 |
Vertex Pharma |
Hepatitis C virus variants
|
US7816348B2
(en)
|
2006-02-03 |
2010-10-19 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US8039475B2
(en)
|
2006-02-27 |
2011-10-18 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
WO2007109080A2
(en)
|
2006-03-16 |
2007-09-27 |
Vertex Pharmaceuticals Incorporated |
Deuterated hepatitis c protease inhibitors
|
US20070287664A1
(en)
*
|
2006-03-23 |
2007-12-13 |
Schering Corporation |
Combinations of HCV protease inhibitor(s) and CYP3A4 inhibitor(s), and methods of treatment related thereto
|
JP5167244B2
(ja)
|
2006-04-11 |
2013-03-21 |
ノバルティス アーゲー |
Hcv/hiv阻害剤およびそれらの使用
|
GB0609492D0
(en)
|
2006-05-15 |
2006-06-21 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
DK2032535T3
(da)
*
|
2006-06-01 |
2012-11-05 |
Sanofi Sa |
Spiro-cycliske nitriler som protease-inhibitorer
|
GB0612423D0
(en)
|
2006-06-23 |
2006-08-02 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
RU2009109355A
(ru)
|
2006-08-17 |
2010-09-27 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
Ингибиторы вырусной полимеразы
|
CN101583372A
(zh)
|
2006-10-24 |
2009-11-18 |
默克公司 |
Hcv ns3蛋白酶抑制剂
|
AU2007309544B2
(en)
|
2006-10-24 |
2012-05-31 |
Msd Italia S.R.L. |
HCV NS3 protease inhibitors
|
CA2667165A1
(en)
|
2006-10-24 |
2008-05-02 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
JP5352464B2
(ja)
|
2006-10-27 |
2013-11-27 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Hcvns3プロテアーゼ阻害剤
|
KR101615500B1
(ko)
|
2006-10-27 |
2016-04-27 |
머크 샤프 앤드 돔 코포레이션 |
Hcv ns3 프로테아제 억제제
|
GB0625345D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
CA2672250C
(en)
|
2006-12-20 |
2013-04-30 |
Ian Stansfield |
Antiviral indoles
|
GB0625349D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
CN101611025A
(zh)
|
2006-12-22 |
2009-12-23 |
先灵公司 |
5,6-环化的吲哚衍生物及其使用方法
|
CA2673254C
(en)
*
|
2006-12-22 |
2013-09-10 |
Schering Corporation |
4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
|
BRPI0720625A2
(pt)
|
2006-12-22 |
2014-03-25 |
Schering Corp |
Derivados de indol de 4,5-anel anulados e métodos de uso dos mesmos
|
JP2010519330A
(ja)
*
|
2007-02-27 |
2010-06-03 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
共結晶体およびそれを含む医薬組成物
|
CN101903392A
(zh)
|
2007-02-27 |
2010-12-01 |
弗特克斯药品有限公司 |
丝氨酸蛋白酶的抑制剂
|
PL2144604T3
(pl)
*
|
2007-02-28 |
2012-02-29 |
Conatus Pharmaceuticals Inc |
Sposoby leczenia przewlekłego zapalenia wątroby typu C z zastosowaniem RO 113-0830
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
CN101754970B
(zh)
|
2007-07-17 |
2013-07-10 |
P.安杰莱蒂分子生物学研究所 |
用于治疗丙型肝炎的大环吲哚衍生物
|
CA2699891C
(en)
|
2007-07-19 |
2013-10-22 |
Nigel Liverton |
Macrocyclic compounds as antiviral agents
|
EP2188274A4
(en)
|
2007-08-03 |
2011-05-25 |
Boehringer Ingelheim Int |
VIRAL POLYMERASE HEMMER
|
TW200911807A
(en)
*
|
2007-08-29 |
2009-03-16 |
Schering Corp |
2,3-substituted azaindole derivatives and methods of use thereof
|
JP5272008B2
(ja)
*
|
2007-08-29 |
2013-08-28 |
メルク・シャープ・アンド・ドーム・コーポレーション |
置換インドール誘導体およびその使用の方法
|
JP5272007B2
(ja)
*
|
2007-08-29 |
2013-08-28 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ウイルス感染症を治療するための2,3−置換インドール誘導体
|
CN101835774B
(zh)
|
2007-08-30 |
2014-09-17 |
弗特克斯药品有限公司 |
共晶体和包含该共晶体的药物组合物
|
US8383583B2
(en)
|
2007-10-26 |
2013-02-26 |
Enanta Pharmaceuticals, Inc. |
Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors
|
JP2011503201A
(ja)
|
2007-11-14 |
2011-01-27 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
大環状テトラゾリルc型肝炎セリンプロテアーゼ阻害剤
|
MX2010005355A
(es)
*
|
2007-11-16 |
2010-06-02 |
Schering Corp |
Derivados de indol sustituidos con 3-aminosulfonilo y metodos de uso de los mismos.
|
WO2009064848A1
(en)
*
|
2007-11-16 |
2009-05-22 |
Schering Corporation |
3-heterocyclic substituted indole derivatives and methods of use thereof
|
US8273709B2
(en)
|
2007-12-14 |
2012-09-25 |
Enanta Pharmaceuticals, Inc. |
Triazole-containing macrocyclic HCV serine protease inhibitors
|
CN101903351B
(zh)
|
2007-12-19 |
2014-09-10 |
贝林格尔.英格海姆国际有限公司 |
病毒聚合酶抑制剂
|
EP2250174B1
(en)
|
2008-02-04 |
2013-08-28 |
IDENIX Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors
|
JP5490778B2
(ja)
|
2008-03-20 |
2014-05-14 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
C型肝炎ウイルス阻害剤としてのフッ素化大環状化合物
|
TW200946541A
(en)
|
2008-03-27 |
2009-11-16 |
Idenix Pharmaceuticals Inc |
Solid forms of an anti-HIV phosphoindole compound
|
JP2011518882A
(ja)
|
2008-04-28 |
2011-06-30 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Hcvns3プロテアーゼ阻害剤
|
EP2303893B1
(en)
*
|
2008-06-13 |
2016-12-07 |
Merck Sharp & Dohme Corp. |
Tricyclic indole derivatives
|
CA2729168A1
(en)
|
2008-07-02 |
2010-02-04 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
DK2310095T3
(da)
|
2008-07-22 |
2012-12-10 |
Merck Sharp & Dohme |
Makrocykliske quinoxalinforbindelser som hcv-ns3-protease-inhibitorer
|
JP5674661B2
(ja)
|
2008-08-20 |
2015-02-25 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
エチニル置換ピリジンおよびピリミジン誘導体ならびにそれらのウイルス感染の治療における使用
|
EP2326626B1
(en)
|
2008-08-20 |
2013-10-16 |
Merck Sharp & Dohme Corp. |
Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
US8470834B2
(en)
|
2008-08-20 |
2013-06-25 |
Merck Sharp & Dohme Corp. |
AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
WO2010022121A1
(en)
|
2008-08-20 |
2010-02-25 |
Schering Corporation |
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
US8044087B2
(en)
*
|
2008-09-29 |
2011-10-25 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
EA019295B1
(ru)
|
2008-12-23 |
2014-02-28 |
Джилид Фармассет, Ллс. |
Соединения пуриновых нуклеозидов и способ их получения
|
US8551973B2
(en)
|
2008-12-23 |
2013-10-08 |
Gilead Pharmasset Llc |
Nucleoside analogs
|
EP2376088B1
(en)
|
2008-12-23 |
2017-02-22 |
Gilead Pharmasset LLC |
6-O-Substituted-2-amino-purine nucleoside phosphoramidates
|
RU2011127080A
(ru)
|
2009-01-07 |
2013-02-20 |
Сайнексис, Инк. |
Производное циклоспорина для применения в лечении заражения вирусом гепатита с и вич
|
WO2010082050A1
(en)
|
2009-01-16 |
2010-07-22 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
US8102720B2
(en)
*
|
2009-02-02 |
2012-01-24 |
Qualcomm Incorporated |
System and method of pulse generation
|
JP5690286B2
(ja)
|
2009-03-04 |
2015-03-25 |
イデニク プハルマセウティカルス,インコーポレイテッド |
ホスホチオフェン及びホスホチアゾールhcvポリメラーゼ阻害剤
|
WO2010118078A1
(en)
|
2009-04-08 |
2010-10-14 |
Idenix Pharmaceuticals, Inc. |
Macrocyclic serine protease inhibitors
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
EP2435424B1
(en)
|
2009-05-29 |
2015-01-21 |
Merck Sharp & Dohme Corp. |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
CN101605432B
(zh)
*
|
2009-07-10 |
2011-08-24 |
番禺南沙殷田化工有限公司 |
刚性印刷电路板的自动湿法贴膜方法
|
EP2459582B1
(en)
|
2009-07-30 |
2015-05-27 |
Merck Sharp & Dohme Corp. |
Hepatitis c virus ns3 protease inhibitors
|
TW201117812A
(en)
|
2009-08-05 |
2011-06-01 |
Idenix Pharmaceuticals Inc |
Macrocyclic serine protease inhibitors
|
US20110117055A1
(en)
|
2009-11-19 |
2011-05-19 |
Macdonald James E |
Methods of Treating Hepatitis C Virus with Oxoacetamide Compounds
|
US20120276047A1
(en)
|
2009-11-25 |
2012-11-01 |
Rosenblum Stuart B |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
RU2554087C2
(ru)
|
2009-12-18 |
2015-06-27 |
Айденикс Фармасьютикалз, Инк. |
5,5-конденсированные ариленовые или гетероариленовые ингибиторы вируса гепатита с
|
CA2785488A1
(en)
|
2009-12-22 |
2011-07-21 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
|
WO2011103441A1
(en)
|
2010-02-18 |
2011-08-25 |
Schering Corporation |
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
BR112012022125A2
(pt)
|
2010-03-09 |
2016-11-01 |
Merck Sharp & Dhme Corp |
composto, sal de dicloridrato, composição farmacêutica, uso do composto, e, método para tratar um paciente
|
JP2013527145A
(ja)
|
2010-03-31 |
2013-06-27 |
ギリード・ファーマセット・エルエルシー |
リン含有活性化剤の立体選択的合成
|
US8680071B2
(en)
|
2010-04-01 |
2014-03-25 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
AU2011286276A1
(en)
|
2010-07-26 |
2013-01-24 |
Merck Sharp & Dohme Corp. |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
WO2012050848A1
(en)
|
2010-09-29 |
2012-04-19 |
Schering Corporation |
Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
|
EP2624826B1
(en)
|
2010-10-08 |
2018-07-18 |
Novartis AG |
Vitamin e formulations of sulfamide ns3 inhibitors
|
AR084044A1
(es)
|
2010-11-30 |
2013-04-17 |
Pharmasset Inc |
Compuestos 2’-espiro-nucleosidos
|
AR085352A1
(es)
|
2011-02-10 |
2013-09-25 |
Idenix Pharmaceuticals Inc |
Inhibidores macrociclicos de serina proteasa, sus composiciones farmaceuticas y su uso para tratar infecciones por hcv
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
JP2014514295A
(ja)
|
2011-03-31 |
2014-06-19 |
アイディニックス ファーマシューティカルズ インコーポレイテッド |
ウイルス感染の治療のための化合物および薬学的組成物
|
BR112013026345A2
(pt)
|
2011-04-13 |
2019-04-24 |
Merck Sharp & Dohe Corp. |
composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv
|
EP2697242B1
(en)
|
2011-04-13 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
WO2013033901A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
|
WO2013033899A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
|
WO2013033900A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
|
JP2014526474A
(ja)
|
2011-09-12 |
2014-10-06 |
アイディニックス ファーマシューティカルズ インコーポレイテッド |
ウイルス感染の治療のための化合物および薬学的組成物
|
EP2755983B1
(en)
|
2011-09-12 |
2017-03-15 |
Idenix Pharmaceuticals LLC. |
Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
|
WO2013039876A1
(en)
|
2011-09-14 |
2013-03-21 |
Merck Sharp & Dohme Corp. |
Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
EP2768838A1
(en)
|
2011-10-14 |
2014-08-27 |
IDENIX Pharmaceuticals, Inc. |
Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
EP2780026B1
(en)
|
2011-11-15 |
2019-10-23 |
Merck Sharp & Dohme Corp. |
Hcv ns3 protease inhibitors
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
AU2012345732B2
(en)
|
2011-11-30 |
2016-07-14 |
Emory University |
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
|
US20140356325A1
(en)
|
2012-01-12 |
2014-12-04 |
Ligand Pharmaceuticals Incorporated |
Novel 2'-c-methyl nucleoside derivative compounds
|
WO2013133927A1
(en)
|
2012-02-13 |
2013-09-12 |
Idenix Pharmaceuticals, Inc. |
Pharmaceutical compositions of 2'-c-methyl-guanosine, 5'-[2-[(3-hydroxy-2,2-dimethyl-1-oxopropyl)thio]ethyl n-(phenylmethyl)phosphoramidate]
|
EP2852605B1
(en)
|
2012-05-22 |
2018-01-31 |
Idenix Pharmaceuticals LLC |
3',5'-cyclic phosphate prodrugs for hcv infection
|
WO2013177188A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphoramidate prodrugs for hcv infection
|
SG11201407674TA
(en)
|
2012-05-22 |
2014-12-30 |
Idenix Pharmaceuticals Inc |
D-amino acid compounds for liver disease
|
UA119315C2
(uk)
|
2012-07-03 |
2019-06-10 |
Гіліад Фармассет Елелсі |
Інгібітори вірусу гепатиту с
|
TR201809048T4
(tr)
|
2012-10-08 |
2018-07-23 |
Centre Nat Rech Scient |
Hcv enfeksiyonu için 2'-kloro nükleosit analogları.
|
US20140112886A1
(en)
|
2012-10-19 |
2014-04-24 |
Idenix Pharmaceuticals, Inc. |
Dinucleotide compounds for hcv infection
|
US10723754B2
(en)
|
2012-10-22 |
2020-07-28 |
Idenix Pharmaceuticals Llc |
2′,4′-bridged nucleosides for HCV infection
|
WO2014078436A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-alanine ester of sp-nucleoside analog
|
EP2920195A1
(en)
|
2012-11-14 |
2015-09-23 |
IDENIX Pharmaceuticals, Inc. |
D-alanine ester of rp-nucleoside analog
|
WO2014099941A1
(en)
|
2012-12-19 |
2014-06-26 |
Idenix Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
WO2014121418A1
(en)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
|
WO2014121417A1
(en)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
|
US9339541B2
(en)
|
2013-03-04 |
2016-05-17 |
Merck Sharp & Dohme Corp. |
Thiophosphate nucleosides for the treatment of HCV
|
EP2970358B1
(en)
|
2013-03-04 |
2021-06-30 |
Idenix Pharmaceuticals LLC |
3'-deoxy nucleosides for the treatment of hcv
|
ES2735355T3
(es)
|
2013-03-15 |
2019-12-18 |
Gilead Sciences Inc |
Inhibidores macrocíclicos y bicíclicos de virus de hepatitis C
|
US9187515B2
(en)
|
2013-04-01 |
2015-11-17 |
Idenix Pharmaceuticals Llc |
2′,4′-fluoro nucleosides for the treatment of HCV
|
WO2014197578A1
(en)
|
2013-06-05 |
2014-12-11 |
Idenix Pharmaceuticals, Inc. |
1',4'-thio nucleosides for the treatment of hcv
|
US20150037282A1
(en)
|
2013-08-01 |
2015-02-05 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
PL3650014T3
(pl)
|
2013-08-27 |
2022-01-31 |
Gilead Pharmasset Llc |
Preparat złożony dwóch związków przeciwwirusowych
|
EP3046924A1
(en)
|
2013-09-20 |
2016-07-27 |
IDENIX Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
WO2015061683A1
(en)
|
2013-10-25 |
2015-04-30 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate and d-alanine thiophosphoramidate pronucleotides of nucleoside compounds useful for the treatment of hcv
|
WO2015065817A1
(en)
|
2013-10-30 |
2015-05-07 |
Merck Sharp & Dohme Corp. |
Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
|
US20160271162A1
(en)
|
2013-11-01 |
2016-09-22 |
Idenix Pharmacueticals, Llc |
D-alanine phosphoramide pronucleotides of 2'-methyl 2'-fluro guanosine nucleoside compounds for the treatment of hcv
|
US20170198005A1
(en)
|
2013-11-27 |
2017-07-13 |
Idenix Pharmaceuticals Llc |
2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection
|
WO2015095419A1
(en)
|
2013-12-18 |
2015-06-25 |
Idenix Pharmaceuticals, Inc. |
4'-or nucleosides for the treatment of hcv
|
EP3105238A4
(en)
|
2014-02-13 |
2017-11-08 |
Ligand Pharmaceuticals, Inc. |
Prodrug compounds and their uses
|
WO2015134560A1
(en)
|
2014-03-05 |
2015-09-11 |
Idenix Pharmaceuticals, Inc. |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
WO2015134780A1
(en)
|
2014-03-05 |
2015-09-11 |
Idenix Pharmaceuticals, Inc. |
Solid prodrug forms of 2'-chloro-2'-methyl uridine for hcv
|
US20170135990A1
(en)
|
2014-03-05 |
2017-05-18 |
Idenix Pharmaceuticals Llc |
Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infection
|
EP3131914B1
(en)
|
2014-04-16 |
2023-05-10 |
Idenix Pharmaceuticals LLC |
3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
|
EP3164136A4
(en)
|
2014-07-02 |
2018-04-04 |
Ligand Pharmaceuticals, Inc. |
Prodrug compounds and uses therof
|
CN105153005A
(zh)
*
|
2015-08-05 |
2015-12-16 |
上海瑞博化学有限公司 |
一种4-羰基-脯氨酸衍生物的制备方法
|
US11091428B2
(en)
*
|
2016-09-13 |
2021-08-17 |
Haplogen Gmbh |
Antiviral compounds
|
CN111788196A
(zh)
|
2018-01-09 |
2020-10-16 |
配体药物公司 |
缩醛化合物及其治疗用途
|